ClinicalTrials.gg
CompletedNCT03426566Updated May 27, 2022Results posted

Abnormal Plantar Pressure in Patients With Diabetes

An observational study in Diabetes Complications, sponsored by Wroclaw Medical University. Completed at 1 site in Poland. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2022-05-27.

Sponsored by Wroclaw Medical University · Observational

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Retrospective
Enrollment
974
Ages
18 Years to 99 Years
Sex
All
01

Study summary

The prevalence of abnormal plantar pressure distribution (APD) and its connection with various factors among patients with diabetes is not known. The purpose of this study was to evaluate the prevalence of the APD and its connection with selected factors among patients with diabetes.

Read the detailed description

The abnormal plantar pressure distribution (APD) plays a key role in the formation of plantar calluses which are responsible for diabetic foot ulcer.

The knowledge of APD is necessary to plan proper prevention in the group of patients with diabetes mellitus (DM).

Medical records from previous patients' visits of non-ulcer patients with diabetes were retrospectively analysed. The relationship between APD, obtained during a pedobarographic test as a semi-quantitative assessment with colourful print analysis, and neuropathy, gender, age and BMI was searched.

02

Conditions studied

  • Diabetes Complications

Keywords

  • diabetic foot
  • pedobarography
  • diabetic neuropathy
  • plantar pressure
03

In context

Diabetes Complications

267 studies on the registry are indexed under Diabetes Complications; 54 are open to participants now.

This study's enrollment of 974 is above the median of 200 across 84 observational studies indexed under Diabetes Complications.

Browse Diabetes Complications studies →

Lead sponsor

Wroclaw Medical University is the lead sponsor of 99 studies on the registry; 29 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Wroclaw (where the Diabetic Foot Centre exists) citizens who came spontaneously to be examined despite the absence of diabetic foot signs or symptoms

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • subjects with diabetes mellitus diagnosis
  • citizens
  • no previous foot ulceration and/or foot surgery

Exclusion criteria

Exclusion Criteria:

  • previous foot ulceration and/or foot surgery
05

Study design

Observational model
Other
Time perspective
Retrospective
Enrollment
974 participants (actual)
Patient registry
No

Groups and cohorts

  • patients with diabetes

    Data from medical records from : non-ulcer patients with DM (diabetes mellitus) from the Diabetic Foot Centre (DFC) in Wroclaw. As it is a retrospective analysis no intervention is planned.

    Other: retrospective observational study with no intervention

Interventions

  • Otherretrospective observational study with no intervention

    no intervention

06

What researchers measure

Primary outcomes

  1. Abnormal Plantar Pressure Distribution

    static pedobarographic test with semi-quantitative assessment: number of the patients with abnormal plantar pressure location based on a semi-quantitative method, as static barefoot pedobarographic records with colourful print analysis. The intensity of colour was proportional to the pressure received. Warm colours indicated the greatest pressure, while cold colours indicated the least plantar pressure (starting with red, then yellow, green, and blue)

    Time frame: 1 visit

Secondary outcomes

  1. Number of Participants With Positive Test for Neuropathy

    Peripheral neuropathy is assessed with questions and clinical evaluation. A nurse asks the patient about stinging, numbness, tingling, or burning of the foot. Ten-gram monofilament and tuning fork (128 MHz) tests are administered. Monofilament is applied in 10 locations on the sole and one on the dorsal part of the foot for checking the loss of protective sensation. A positive monofilament test is considered to be the lack of sensation of tightness in at least 6 of 11 tested sites. The tuning fork is applied for vibration detection to both ankles, the first metatarsophalangeal joint, and the anterior aspect of the shin bone sites. A positive vibration test is considered to be no detection of vibration in three of four test sites.Two positive test results and typical symptoms of neuropathy are the basis for confirmation of peripheral symmetric sensory neuropathy (PSSN). The condition required for the occurrence of these disorders was symmetry.

    Time frame: 1 visit

  2. BMI

    kg/m2

    Time frame: 1 visit

07

Results

Posted Jun 17, 2019
Limitations and caveats
Lack of the influence of a type and duration of diabetes mellitus.The neuropathy evaluation based on local recommendations. The semi-quantitative analysis of the pressure map; the retrospective nature of the study.

Participant flow

Recruitment period: between October 2009 and December 2010 Medical records were obtained from the Diabetic Foot Centre (DFC) in Wroclaw, Poland and covered a period of fifteen months of work.

Participant flow — Overall Study
MilestonePatients With Diabetes
Started974
Completed974
Not completed0

Outcome measures

PrimaryAbnormal Plantar Pressure Distribution

static pedobarographic test with semi-quantitative assessment: number of the patients with abnormal plantar pressure location based on a semi-quantitative method, as static barefoot pedobarographic records with colourful print analysis. The intensity of colour was proportional to the pressure received. Warm colours indicated the greatest pressure, while cold colours indicated the least plantar pressure (starting with red, then yellow, green, and blue)

Time frame:
1 visit
Reported as:
Count of participants · Participants
Abnormal Plantar Pressure Distribution
ParticipantsPatients With Diabetes
patients without APD80
patients with APD894
SecondaryNumber of Participants With Positive Test for Neuropathy

Peripheral neuropathy is assessed with questions and clinical evaluation. A nurse asks the patient about stinging, numbness, tingling, or burning of the foot. Ten-gram monofilament and tuning fork (128 MHz) tests are administered. Monofilament is applied in 10 locations on the sole and one on the dorsal part of the foot for checking the loss of protective sensation. A positive monofilament test is considered to be the lack of sensation of tightness in at least 6 of 11 tested sites. The tuning fork is applied for vibration detection to both ankles, the first metatarsophalangeal joint, and the anterior aspect of the shin bone sites. A positive vibration test is considered to be no detection of vibration in three of four test sites.Two positive test results and typical symptoms of neuropathy are the basis for confirmation of peripheral symmetric sensory neuropathy (PSSN). The condition required for the occurrence of these disorders was symmetry.

Time frame:
1 visit
Reported as:
Count of participants · Participants
Number of Participants With Positive Test for Neuropathy
ParticipantsPatients With Diabetes
PSSN — negative907
PSSN — positive67
MN calluses — negative645
MN calluses — positive329
MN feet deformity — negative798
MN feet deformity — positive176
SecondaryBMI

kg/m2

Time frame:
1 visit
Reported as:
Count of participants · Participants
BMI
ParticipantsPatients With Diabetes
BMI ≥35 kg/m2153
BMI<35 kg/m2821

Adverse events

Collected over Not applicable- observational, retrospective study with medical-records analysis.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Patients With Diabetes———

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Patients With Diabetes
<=18 years0
Between 18 and 65 years478
>=65 years496
Age, Continuous
Age, Continuous(years)Patients With Diabetes
Mean64.6 ± 11.15
Sex: Female, Male
Sex: Female, Male(Participants)Patients With Diabetes
Female523
Male451
Region of Enrollment
Region of Enrollment(participants)Patients With Diabetes
Poland974
08

Study locations

1 site
  • Department and Division of Medical Rehabilitation
    Wroclaw, Lower Silesia 54-438, Poland
09

References and documents

Publications

  • Boulton AJ, Hardisty CA, Betts RP, Franks CI, Worth RC, Ward JD, Duckworth T. Dynamic foot pressure and other studies as diagnostic and management aids in diabetic neuropathy. Diabetes Care. 1983 Jan-Feb;6(1):26-33. doi: 10.2337/diacare.6.1.26. PubMed 6839919 ↗
  • Boulton AJ, Betts RP, Franks CI, Newrick PG, Ward JD, Duckworth T. Abnormalities of foot pressure in early diabetic neuropathy. Diabet Med. 1987 May-Jun;4(3):225-8. doi: 10.1111/j.1464-5491.1987.tb00867.x. PubMed 2956023 ↗
  • Duckworth T, Boulton AJ, Betts RP, Franks CI, Ward JD. Plantar pressure measurements and the prevention of ulceration in the diabetic foot. J Bone Joint Surg Br. 1985 Jan;67(1):79-85. doi: 10.1302/0301-620X.67B1.3968150. PubMed 3968150 ↗
  • Rich J, Veves A. Forefoot and rearfoot plantar pressures in diabetic patients: correlation to foot ulceration. Wounds2000;12:82-87
  • Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care. 1998 Oct;21(10):1714-9. doi: 10.2337/diacare.21.10.1714. PubMed 9773736 ↗
  • Bakker K, Schaper NC; International Working Group on Diabetic Foot Editorial Board. The development of global consensus guidelines on the management and prevention of the diabetic foot 2011. Diabetes Metab Res Rev. 2012 Feb;28 Suppl 1:116-8. doi: 10.1002/dmrr.2254. PubMed 22271736 ↗
  • Choi YR, Lee HS, Kim DE, Lee DH, Kim JM, Ahn JY. The diagnostic value of pedobarography. Orthopedics. 2014 Dec;37(12):e1063-7. doi: 10.3928/01477447-20141124-52. PubMed 25437079 ↗
  • Bakker K, Apelqvist J, Lipsky BA, Van Netten JJ; International Working Group on the Diabetic Foot. The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence-based global consensus. Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:2-6. doi: 10.1002/dmrr.2694. PubMed 26409930 ↗
  • Crawford F, Cezard G, Chappell FM, Murray GD, Price JF, Sheikh A, Simpson CR, Stansby GP, Young MJ. A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS). Health Technol Assess. 2015 Jul;19(57):1-210. doi: 10.3310/hta19570. PubMed 26211920 ↗
  • Inlow S. The 60-second Foot Exam for People with Diabetes. Wound Care Can2004;2:10-11
  • Carreau L, Niezgoda H, LeBlond S, Trainor A, Orsted H, Woodbury MG. A prospective, descriptive study to assess the reliability and usability of a rapid foot screen for patients with diabetes mellitus in a complex continuing care setting. Ostomy Wound Manage. 2013 Jan;59(1):28-34. PubMed 23308404 ↗
  • Tuna H, Birtane M, Güldiken S et al. The effect of disease duration on foot plantar pressure values in patients with type 2 diabetes mellitus. Turk J Phys Med Rehab2014;60:231-235
  • Lazaro-Martinez JL, Aragon-Sanchez FJ, Beneit-Montesinos JV, Gonzalez-Jurado MA, Garcia Morales E, Martinez Hernandez D. Foot biomechanics in patients with diabetes mellitus: doubts regarding the relationship between neuropathy, foot motion, and deformities. J Am Podiatr Med Assoc. 2011 May-Jun;101(3):208-14. doi: 10.7547/1010208. PubMed 21622632 ↗
  • Perell KL, Merrill V, Nouvong A. Location of plantar ulcerations in diabetic patients referred to a Department of Veterans Affairs podiatry clinic. J Rehabil Res Dev. 2006 Jul-Aug;43(4):421-6. doi: 10.1682/jrrd.2005.10.0157. PubMed 17123181 ↗
  • Ledoux WR, Shofer JB, Cowley MS, Ahroni JH, Cohen V, Boyko EJ. Diabetic foot ulcer incidence in relation to plantar pressure magnitude and measurement location. J Diabetes Complications. 2013 Nov-Dec;27(6):621-6. doi: 10.1016/j.jdiacomp.2013.07.004. Epub 2013 Sep 4. PubMed 24012295 ↗
  • Hills AP, Hennig EM, McDonald M, Bar-Or O. Plantar pressure differences between obese and non-obese adults: a biomechanical analysis. Int J Obes Relat Metab Disord. 2001 Nov;25(11):1674-9. doi: 10.1038/sj.ijo.0801785. PubMed 11753590 ↗
  • Sutkowska E, Fortuna P, Kaluza B, Sutkowska K, Hodurek P, Fleszar MG. The impact of Sample Handling Time on metformin serum concentration. Biomed Pharmacother. 2021 Jan;133:110971. doi: 10.1016/j.biopha.2020.110971. Epub 2020 Nov 25. PubMed 33248407 ↗
  • Sutkowska E, Sutkowski K, Sokolowski M, Franek E, Dragan S Sr. Distribution of the Highest Plantar Pressure Regions in Patients with Diabetes and Its Association with Peripheral Neuropathy, Gender, Age, and BMI: One Centre Study. J Diabetes Res. 2019 Jul 9;2019:7395769. doi: 10.1155/2019/7395769. eCollection 2019. PubMed 31380446 ↗

Individual participant data

Plan to share: Yes — all collected individual participant data but without individual foot-print picture (mostly paper documentation) ; only the example of foot -print with explanation is available

Supporting information: Study protocol, Statistical analysis plan

Time frame: no limit

Access criteria: will be included in an article and/or as supplementary materials

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2012 to primary completion in Dec 2012, 3 months.

Results were first posted in Jun 2019, 6 years 6 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 23, 2018
First posted
Feb 8, 2018
StartActual
Sep 2012
Primary completionActual
Dec 2012
CompletionActual
Jan 2014
Results first posted
Jun 17, 2019
Last update
May 27, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 27, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03426566
Lead sponsor
Wroclaw Medical University
Responsible party
Edyta Sutkowska (MD, PhD; Head of the Department and Division of Medical Rehabilitation, Wroclaw Medical University) — Principal investigator
First posted
Feb 8, 2018
Start date
Sep 2012
Primary completion
Dec 2012
Completion
Jan 2014
Results posted
Jun 17, 2019
Last update
May 27, 2022

Study contacts

Edyta Sutkowska, PhD
principal investigator · Wroclaw Medical University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion